Ian Pitha is an Ophthalmology physician. OpenAlex indexes 78 publications with 4,008 citations (h-index 25).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
517 S Euclid Ave
Saint Louis, MO 631101007
Telephone
314-362-3431Provider last certified this registry record 10 Mar 2025.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- W. L. Gore & Associates, Inc.Program year202512 payments$13,583openpaymentsdata.cms.gov ↗
- Alcon Vision LLCProgram year20252 payments
- ABBVIE INC.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
85.8%Prostaglandin Analog44.1%Latanoprost91%Travoprost5%Lumigan5%Part D≥290 patientsCarbonic Anhydrase Inhibitor21.7%Dorzolamide-Timolol80%Dorzolamide Hcl13%Simbrinza5%Brinzolamide3%Part D<11 patients+ 3 more classes in this area
Cardiovascular
13.2%Beta blocker13.2%Timolol Maleate100%Part D<11 patientsMusculoskeletal
1%Cyclooxygenase Inhibitor1%Ketorolac Tromethamine100%Part D≥15 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Clinical Outcomes of Hydrus Microstent Implantation for Open-Angle Glaucoma
Ophthalmology Glaucoma
2025 - The relationship between intraocular pressure and glaucoma: An evolving concept
Progress in Retinal and Eye Research
2024 - The Mechanisms of Neuroprotection by Topical Rho Kinase Inhibition in Experimental Mouse Glaucoma and Optic Neuropathy
Investigative Ophthalmology & Visual Science
2024 - Cyclic strain alters the transcriptional and migratory response of scleral fibroblasts to TGFβ
Experimental Eye Research
2024
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Emily Chew, MD
National Eye Institute
Robert Weinreb, MD
University of California San Diego
Harry Quigley, MD
Johns Hopkins University School of Medicine
Joel Schuman, MD
Wills Eye Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”